AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2012 prescription drug sales (after Pfizer, Sanofi, Novartis, Merck & Co., Roche and GlaxoSmithKline) and has operations in over 100 countries. [1]
Above text from Wikipedia is available under the CC-BY-SA license.

$2,016,000 spent on lobbying in US, covers roughly through Q3, 2013 [2]

UK government doesn't require disclosure of lobbying spend in UK.

Dec 2011 - Feb 2012

  • Edelman provided UK public affairs consultancy services to Astra Zeneca. [14]

Jun 2011 - Aug 2011

Sep 2010 - Nov 2010

  • EDELMAN provided UK public affairs consultancy services to Astra Zeneca. [12]

September 2011

Dept. for Business, Innovation and Skills
  • Astra Zeneca met with David Willetts, Minister of State, to discuss science, along with 26 others. [3]

July 2011

Dept. for Business, Innovation and Skills
  • AstraZeneca UK met with Stephen Green, Minister of State, to discuss trade and investment. [3]
  • AstraZeneca met with David Willetts, Minister of State, to discuss science and business, along with 9 others. [3]
  • AstraZeneca met with David Willetts, Minister of State, to discuss business. [3]
Her Majesty's Treasury

June 2011

Her Majesty's Treasury
Prime Minister's Office

May 2011

Dept. for Business, Innovation and Skills
  • AstraZeneca plc met with Vincent Cable, Secretary of State for Business, Innovation and Skills, to discuss pharmaceuticals industry. [5]

April 2011

Dept. for Business, Innovation and Skills
  • AstraZeneca met with Edward Davey, Minister for Employment Relations, Consumer and Postal Affairs, to discuss employment relations, along with 13 others. [5]

February 2011

Her Majesty's Treasury

January 2011

Her Majesty's Treasury

December 2010

Her Majesty's Treasury
  • AstraZeneca met with David Gauke, Exchequer Secretary to the Treasury, to discuss Joint Key Interest Groups Briefing with HMRC, along with 13 others. [9]

September 2010

Dept. of Health
  • AstraZeneca met with Frederick Curzon, Parliamentary Under-Secretary of State, for introductory meeting. [11]

August 2010

Dept. for Business, Innovation and Skills
  • AstraZeneca met with David Willetts, Minister of State, to discuss science, along with 18 others. [10]

This profile was compiled by Who's Lobbying and is about AstraZeneca.

This page is not endorsed by or affiliated with AstraZeneca.

Problem with this information?

Please let us know by emailing: